- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Aliskiren – July 2010
ALISKIREN, tablets, 150 mg and 300 mg (as hemifumarate), Rasilez®, July 2010
Last updated
3 November 2010